Technology exploitation paths combining technological and complementary resources in new product development and licensing
Jump to navigation
Jump to search
Target Article[edit | edit source]
Technology exploitation paths combining technological and complementary resources in new product development and licensing; M Bianchi, F Frattini, J Lejarragaae; 2014; doi_citing_unknown
Retraction[edit | edit source]
Retraction: Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/ cisplatin in patients with locally advanced and metastatic bladder cancer (DOI:10.1093/annonc/mdj965); J. T. Roberts, H. von der Maase, L. Sengeløv, P. F. Conte, L. Dogliotti, T. Oliver, M. J. Moore, A. ; 2011-11-1
Citation piece[edit | edit source]
Note: Open to append information.